newsfilter
← Latest News
GlobeNewswire·

Caladrius Biosciences Closes $25.0 Million Private Placement

BASKING RIDGE, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...